Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease
Rebecca Mellema, Freelance Science Communicator, shared a post on LinkedIn:
“New Journal Club video!
This time, we’ll be visiting my own paper: “Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease.”
Authors: Mellema RA, Queisser KA, Ajanel A, Albtoush N, Smith-Sanchez L, Rondina MT, Will J, Valentine JF, Petrey AC.
Due to issues with Adobe Premier (and not wanting to waste all my footage), I had to split my video into 2 parts as well as delete some content, such as brief summaries of the experiments I like to have at the video intro. I apologize for that! It’s not my intention to cut out such a crucial part! (But I also had to stop my computer from crashing)”
Proceed to the videos (part one, part two) attached to the post.
Title: Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Authors: Rebecca A. Mellema, Kimberly A. Queisser, Abigail Ajanel, Nansy Albtoush, Lydia Smith-Sanchez, Matthew T. Rondina, Julie Will, John F. Valentine, Aaron C. Petrey
Read the Full Article on Blood
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children